Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter

Journal of Neuroscience

Volumn 18, Issue 13, 1998, Pages 4861-4869

  Fumagalli, Fabio ^a,b   Gainetdinov, Raul R ^a,c   Valenzano, Kenneth J ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

Dopamine transporter; Free radical; GFAP; Methamphetamine; Microdialysis; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; MESSENGER RNA; METHAMPHETAMINE; PROTEIN; SEROTONIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; MOUSE; NEUROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM;

EID: 0032125186     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-13-04861.1998     Document Type: Article

References (63)

1. Albers DS, Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275:1104-1114.
2. Ali SF, Newport CD, Holson RR, Slikker Jr W, Bowyer JF (1994) Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
3. Ali SF, Newport GD, Slikker Jr W (1996) Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents. Ann NY Acad Sci 801:187-198.
4. Axt KJ, Commins DL, Vosmer G, Seiden LS (1990) α-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation. Brain Res 515:269-276.
5. Bowyer JF, Tank AW, Newport GD, Slikker Jr W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in striatum. J Pharmacol Exp Ther 260:817-824.
6. Bowyer JF, Davied DL, Schmued L, Broening HW, Newport GD, Slikker Jr W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
7. Bowyer JF, Clausing P, Gough B, Slikker Jr W, Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62-70.
8. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein CJ (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/ zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
9. Cappon GD, Morford LRL, Vorhees CV (1997) Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Dev Brain Res 103:155-162.
10. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmeidebergs Arch Pharmacol 275:153-168.
11. Chiang CS, Stalder A, Samimi A, Campbell IL (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-222.
12. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
13. Coudray C, Talla M, Martin S, Fatome M, Favier A (1995) Highperformance liquid-chromatography electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress. Anal Biochem 227:101-111.
14. Cubells JF, Rayport S, Rajindron G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular stress. J Neurosci 14:2260-2771.
15. De Vito MJ, Wagner GC (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28:1145-1150.
16. Farfel GM, Seiden LS (1995) Role of hyperthermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine, and dextromethorphan. J Pharmacol Exp Ther 272:868-875.
17. Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR (1997a) A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur J Pharmacol 323:R9-R10.
18. Fleckenstein AE, Wilkins D, Gibb JW, Hanson GR (1997b) Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 283:281-285.
19. Fleckenstein AE, Metzger RR, Beyeler ML, Gibb JW, Hanson GR (1997c) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur J Pharmacol 334:111-114.
20. Franklin KBJ, Paxinos G (1996) The mouse brain in stereotaxic coordinates. San Diego: Academic.
21. Fumagalli F, Jones SR, Caron MG, Seidler FJ, Slotkin TA (1996) Expression of mRNA coding for the serotonin transporter in aged vs young rat brain: differential effects of glucocorticoids. Brain Res 719:225-228.
22. Gainetdinov RR, Fumagalli F, Jones SR, Caron MG (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J Neurochem 69:1322-1325.
23. Gibb JW, Kogan FJ (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase. Naunyn Schmiedebergs Arch Pharmacol 310:185-187.
24. Gibb JW, Hanson GR, Johnson M (1994) Neurochemical mechanisms of toxicity. In: Amphetamine and its analogs: ncuropsychopharmacology, toxicology and abuse (Cho AK, Segal DS, eds), p 269. San Diego: Academic.
25. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
26. Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophane hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262.
27. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 166:261-269.
28. Itzhak Y, Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773.
29. Johnson M, Stone DM, Hanson GR, Gibb JW (1987) Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur J Pharmacol 135:231-234.
30. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998a) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95:4029-4034.
31. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998b) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
32. 3H] dopamine from isolated corpus striatum by amphetamine, fenfluramine, and unlabeled dopamine. Biochem Pharmacol 31:983-992.
33. Liang NY, Rutledge CO (1982b) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 31:2479-2484.
34. Mack F, Bonisch H (1979) Dissociation constants and lipophicility of catecholamines and related compounds. Naunyn Schmiedebergs Arch Pharmacol 310:1-9.
35. Marek GJ, Vosmer G, Seiden LS (1990a) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res 513:274-279.
36. Marek GJ, Vosmer G, Seiden LS (1990b) The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depictions, and locomotor activity in the rat. Brain Res 516:1-7.
37. +. J Neural Transm 89:139-145.
38. O'Dell SJ, Weihmuller FB, Marshall JF (1992) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256-260.
39. O'Dell SJ, Weihmuller FB, Marshall JF (1993) Methamphetamineinduced DA overflow and injury to striatal DA terminals: attenuation by DA D1 or D2 antagonists. J Neurochem 60:1792-1799.
40. Ohmori T, Abekawa T, Koyama T (1996) The role of glutamate in the neurotoxic effects of methamphetamine. Ann NY Acad Sci 801:315-326.
41. Pu C, Vorhees CV (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Dev Brain Res 72:325-328.
42. Pu C, Fisher JE, Cappon GD, Vorhees CV (1994) The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamineinduced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res 649:217-224.
43. Raiteri M, Cerrito F, Cervoni AM, Levi G (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195-202.
44. Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153-163.
45. Ricaurte GA, Fuller RW, Perry KW, Seiden LS, Schuster CR (1983) Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of D-metamphetamine and D-amphetamine. Neuropharmacology 22:1165-1169.
46. Ricaurte GA, Sabol KE, Seiden LS (1994) Functional consequences of neurotoxic amphetamine exposure. In: Amphetamine and its analogs: neuropsychopharmacology, toxicology and abuse (Cho AK, Segal DS, eds), pp 297-313. Orlando, FL: Academic.
47. Schmidt CJ, Gibb JW (1985a) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur J Pharmacol 109:73-80.
48. Schmidt CJ, Gibb JW (1985b) Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine. Neurochem Res 10:637-648.
49. Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther 233:539-544.
50. Seiden LS, Ricaurte G (1987) Neurotoxicity of methamphetamine and related drugs. In: Psychopharmacology: the third generation of progress (Meltzer HY, ed), pp 359-365. New York: Raven.
51. Seiden LS, Sabol KE (1995) Neurotoxicity of methamphetamine-related drugs and cocaine. In: Handbook of neurotoxicology (Chang LW, Dyer RS, eds), pp 825-843. New York: Dekker.
52. Seiden LS, Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol Biochem Behav 21:29-31.
53. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32:639-677.
54. Sonsalla PK, Gibb JW, Hanson GR (1986) Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 238:932-937.
55. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostnatal dopaminergic toxicity. Science 243:398-400.
56. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
57. Wagner GC, Ricaurte G, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
58. Wagner GC, Lucot JB, Schuster CR, Seiden LS (1983) α-Methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res 270:285-288.
59. Wagner GC, Carelli RM, Jarvis MF (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Commun Chem Pathol Pharmacol 47:221-228.
60. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG (1997) Knock-out of the vesicular monoamine transporter-2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285-1296.
61. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703.
62. 3H]amphetamine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 257:830-835.
63. 3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. J Pharmacol Exp Ther 257:820-829.